Skip to main content
. 2022 Aug 13;11(4):1267–1285. doi: 10.1007/s40122-022-00424-7

Table 4.

Modified Patient Reported Treatment Impact (mPRTI) scores at week 16 and week 56

Placebo (N = 406) Tanezumab 5 mg (N = 407) Tanezumab 10 mg (N = 407) Tramadol (N = 605)
Week 16
 Current or most recent treatment you were receiving for low back pain before enrolling? Injectable prescription medicines 20 (6.2%) 21 (6.3%) 22 (6.5%) 39 (8.7%)
Prescription medicines taken by mouth 213 (66.1%) 211 (63.4%) 229 (67.4%) 287 (63.8%)
Surgery 2 (< 1.0%) 2 (< 1.0%) 1 (< 1.0%) 1 (< 1.0%)
Prescription medicines and surgery 7 (2.2%) 9 (2.7%) 10 (2.9%) 14 (3.1%)
No treatment 80 (24.8%) 90 (27.0%) 78 (22.9%) 109 (24.2%)
 Overall, do you prefer the drug that you received in this study to previous treatment? Yes, I definitely prefer the drug that I am receiving now 150 (46.6%) 172 (51.7%) 191 (56.2%) 232 (51.6%)
I have a slight preference for the drug that I am receiving now 57 (17.7%) 62 (18.6%) 50 (14.7%) 89 (19.8%)
I have no preference either way 62 (19.3%) 66 (19.8%) 55 (16.2%) 82 (18.2%)
I have a slight preference for my previous treatment 24 (7.5%) 14 (4.2%) 23 (6.8%) 17 (3.8%)
No, I definitely prefer my previous treatment 29 (9.0%) 19 (5.7%) 21 (6.2%) 30 (6.7%)
  p value vs placebo 0.0333 0.0244 0.0265
  p value vs tramadol 0.9512 0.8052
 Willing to use the same drug that you have received in this study for your low back pain? Yes, I would definitely want to use the same drug again 167 (51.9%) 191 (57.4%) 210 (61.8%) 251 (55.8%)
I might want to use the same drug again 61 (18.9%) 80 (24.0%) 58 (17.1%) 98 (21.8%)
I am not sure 51 (15.8%) 36 (10.8%) 38 (11.2%) 64 (14.2%)
I might not want to use the same drug again 11 (3.4%) 10 (3.0%) 13 (3.8%) 13 (2.9%)
No, I definitely would not want to use the same drug again 32 (9.9%) 16 (4.8%) 21 (6.2%) 24 (5.3%)
  p value vs placebo 0.0045 0.0099 0.0206
  p value vs tramadol 0.4266 0.5733
Week 56
 Current or most recent treatment you were receiving for low back pain before enrolling? Injectable prescription medicines 6 (4.3%) 13 (8.2%) 9 (4.4%)
Prescription medicines taken by mouth 91 (64.5%) 102 (64.2%) 147 (71.4%)
Surgery 2 (1.4%) 0 3 (1.5%)
Prescription medicines and surgery 7 (5.0%) 4 (2.5%) 3 (1.5%)
No treatment 35 (24.8%) 40 (25.2%) 44 (21.4%)
 Overall, do you prefer the drug that you received in this study to previous treatment? Yes, I definitely prefer the drug that I am receiving now 90 (63.8%) 104 (65.4%) 129 (62.6%)
I have a slight preference for the drug that I am receiving now 30 (21.3%) 36 (22.6%) 42 (20.4%)
I have no preference either way 15 (10.6%) 12 (7.5%) 22 (10.7%)
I have a slight preference for my previous treatment 2 (1.4%) 4 (2.5%) 7 (3.4%)
No, I definitely prefer my previous treatment 4 (2.8%) 3 (1.9%) 6 (2.9%)
  p value vs tramadol 0.6107 0.2846
 Willing to use the same drug that you have received in this study for your low back pain? Yes, I would definitely want to use the same drug again 99 (70.2%) 114 (71.7%) 133 (64.6%)
I might want to use the same drug again 23 (16.3%) 31 (19.5%) 41 (19.9%)
I am not sure 15 (10.6%) 10 (6.3%) 26 (12.6%)
I might not want to use the same drug again 0 2 (1.3%) 4 (1.9%)
No, I definitely would not want to use the same drug again 4 (2.8%) 2 (1.3%) 2 (< 1.0%)
  p value vs tramadol 0.5358 0.1082

Week 16 n was 322, 333, 340, and 450 for placebo, tanezumab 5 mg, tanezumab 10 mg, and tramadol, respectively

Week 56 n week 56 was 141, 159, and 206 for tanezumab 5 mg, tanezumab 10 mg, and tramadol, respectively